Vanessa Boudewyns
Dados Biográficos
| ID | 1682240 |
|---|---|
| NOME | Vanessa Boudewyns |
| PRENOMES | Vanessa |
| SOBRENOME | Boudewyns |
| ASSINATURA | BOUDEWYNS V |
| AFILIAÇÕES | RTI International |
| ORCID | 0000-0002-1777-290X |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 12 |
| TOTAL DE CITAÇÕES | 6 |
| TOTAL COMO AUTOR | 12 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2012 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2026 |
| ÍNDICE H | 2 |
Current Contraceptive Practices and Pre-exposure Prophylaxis Modality Preferences among Black and Non-Black Women in the United States
Stigma and HIV testing behavior in a nationally representative sample of US adults
Research has examined the impact of HIV stigma on people with HIV (PWH), but little work has explored how stigmatizing beliefs toward PWH and instrumental stigma - the misplaced fears of infection through everyday contact with PWH - may serve as a barrier to HIV testing. We analyzed responses from 3,271 US adults in the fall 2021 ConsumerStyles Survey to estimate the prevalence of these stigmas and examine associations with sociodemographic facto…
Examining the Association Between Exposure to the #ShesWell Campaign and Black Women’s Conversations with Healthcare Providers About Pre-Exposure Prophylaxis (PrEP)
Low uptake of pre-exposure prophylaxis (PrEP) for HIV prevention among Black women has been partly attributed to barriers related to patient-provider communication. The goal of this paper was to investigate the association between exposure to the #ShesWell campaign and Black women's communication about PrEP with a healthcare provider (HCP). We conducted a cross-sectional survey of 403 sexually active, Black women after the initial phase of #ShesW…
The Impact of Stigma on U.S. Health Care Provider Perceptions, Treatment, and Care of People who May Be Exposed To or Living with HIV
Impact of #ShesWell Campaign on PrEP Beliefs and Intentions in Black Women
Implied Claims in Drug Advertising
Federal agencies and self-regulatory bodies help to ensure prescription and nonprescription drug promotion contains accurate information; however, false or misleading claims may cause people to have inaccurate perceptions of a drug and inhibit their ability to make informed decisions. We conducted a systematic review assessing evidence from 2012-2021 on how consumers and healthcare providers (HCPs) interpret claims made indirectly or through infe…
Message Framing Strategies to Promote the Uptake of PrEP
Detecting and Reporting Deceptive Prescription Drug Promotion
The U.S. Food and Drug Administration’s (FDA) Bad Ad program provides an avenue for healthcare providers to report false or misleading prescription drug promotion. Yet, whether healthcare providers can detect such promotion, and whether they believe it should be reported to FDA, remain open questions. Consumer audiences may also be capable of detecting such promotion and believe it should be reported, but even less is known about capability and b…
Defining and Measuring Scientific Misinformation
We define scientific misinformation as publicly available information that is misleading or deceptive relative to the best available scientific evidence and that runs contrary to statements by actors or institutions who adhere to scientific principles. Scientific misinformation violates the supposition that claims should be based on scientific evidence and relevant expertise. As such, misinformation is observable and measurable, but research on s…
An Empirical Procedure to Evaluate Misinformation Rejection and Deception in Mediated Communication Contexts
Although misleading health information is not a new phenomenon, no standards exist to assess consumers’ ability to detect and subsequently reject misinformation. Part of this deficit reflects theoretical and measurement challenges. After drawing novel connections among legal, regulatory, and philosophical perspectives on false, misleading or deceptive advertising and cognitive-process models of persuasive communication, we define deception and mi…
Misinformation and Mass Audiences
The Health Literacy Skills Framework
Although there are a variety of models and frameworks that describe factors that are associated with health literacy skills, few illustrate the full pathway from development and moderators of health literacy skills, their application, and the outcomes that result all in one framework or model. This article introduces the Health Literacy Skills conceptual framework that does encompass this full continuum. To develop the framework, the authors revi…
Defining and Measuring Scientific Misinformation
We define scientific misinformation as publicly available information that is misleading or deceptive relative to the best available scientific evidence and that runs contrary to statements by actors or institutions who adhere to scientific principles. Scientific misinformation violates the supposition that claims should be based on scientific evidence and relevant expertise. As such, misinformation is observable and measurable, but research on s…
An Empirical Procedure to Evaluate Misinformation Rejection and Deception in Mediated Communication Contexts
Although misleading health information is not a new phenomenon, no standards exist to assess consumers’ ability to detect and subsequently reject misinformation. Part of this deficit reflects theoretical and measurement challenges. After drawing novel connections among legal, regulatory, and philosophical perspectives on false, misleading or deceptive advertising and cognitive-process models of persuasive communication, we define deception and mi…
The Health Literacy Skills Framework
Although there are a variety of models and frameworks that describe factors that are associated with health literacy skills, few illustrate the full pathway from development and moderators of health literacy skills, their application, and the outcomes that result all in one framework or model. This article introduces the Health Literacy Skills conceptual framework that does encompass this full continuum. To develop the framework, the authors revi…
Misinformation and Mass Audiences
An Empirical Procedure to Evaluate Misinformation Rejection and Deception in Mediated Communication Contexts
Although misleading health information is not a new phenomenon, no standards exist to assess consumers’ ability to detect and subsequently reject misinformation. Part of this deficit reflects theoretical and measurement challenges. After drawing novel connections among legal, regulatory, and philosophical perspectives on false, misleading or deceptive advertising and cognitive-process models of persuasive communication, we define deception and mi…
Detecting and Reporting Deceptive Prescription Drug Promotion
The U.S. Food and Drug Administration’s (FDA) Bad Ad program provides an avenue for healthcare providers to report false or misleading prescription drug promotion. Yet, whether healthcare providers can detect such promotion, and whether they believe it should be reported to FDA, remain open questions. Consumer audiences may also be capable of detecting such promotion and believe it should be reported, but even less is known about capability and b…
Defining and Measuring Scientific Misinformation
We define scientific misinformation as publicly available information that is misleading or deceptive relative to the best available scientific evidence and that runs contrary to statements by actors or institutions who adhere to scientific principles. Scientific misinformation violates the supposition that claims should be based on scientific evidence and relevant expertise. As such, misinformation is observable and measurable, but research on s…
Message Framing Strategies to Promote the Uptake of PrEP
Implied Claims in Drug Advertising
Federal agencies and self-regulatory bodies help to ensure prescription and nonprescription drug promotion contains accurate information; however, false or misleading claims may cause people to have inaccurate perceptions of a drug and inhibit their ability to make informed decisions. We conducted a systematic review assessing evidence from 2012-2021 on how consumers and healthcare providers (HCPs) interpret claims made indirectly or through infe…
Examining the Association Between Exposure to the #ShesWell Campaign and Black Women’s Conversations with Healthcare Providers About Pre-Exposure Prophylaxis (PrEP)
Low uptake of pre-exposure prophylaxis (PrEP) for HIV prevention among Black women has been partly attributed to barriers related to patient-provider communication. The goal of this paper was to investigate the association between exposure to the #ShesWell campaign and Black women's communication about PrEP with a healthcare provider (HCP). We conducted a cross-sectional survey of 403 sexually active, Black women after the initial phase of #ShesW…
The Impact of Stigma on U.S. Health Care Provider Perceptions, Treatment, and Care of People who May Be Exposed To or Living with HIV
Impact of #ShesWell Campaign on PrEP Beliefs and Intentions in Black Women
Current Contraceptive Practices and Pre-exposure Prophylaxis Modality Preferences among Black and Non-Black Women in the United States
Stigma and HIV testing behavior in a nationally representative sample of US adults
Research has examined the impact of HIV stigma on people with HIV (PWH), but little work has explored how stigmatizing beliefs toward PWH and instrumental stigma - the misplaced fears of infection through everyday contact with PWH - may serve as a barrier to HIV testing. We analyzed responses from 3,271 US adults in the fall 2021 ConsumerStyles Survey to estimate the prevalence of these stigmas and examine associations with sociodemographic facto…
Psychology (7 obras) · Public health (6 obras) · Computer Science (4 obras) · Health care (4 obras) · HIV/AIDS Research and Interventions (4 obras) · Internet privacy (4 obras) · Medicine (4 obras) · Misinformation and Its Impacts (4 obras) · Pre-exposure prophylaxis (4 obras) · Advertising (3 obras)